Peter Löw

Suppression of HHV-8 viremia by foscarnet in an HIV-infected patient with Kaposi's sarcoma and HHV-8 associated hemophagocytic syndrome.

Peter Löw, Frank Neipel, Astrid Rascu et al. · PubMed · 1998 · 53 citations

Initiation of HAART in Drug-Naive HIV Type 1 Patients Prevents Viral Breakthrough for a Median Period of 35.5 Months in 60% of the Patients

Kristien Van Vaerenbergh, Thomas Harrer, Jean‐Claude Schmit et al. · AIDS Research and Human Retroviruses · 2002 · 22 citations

Daily Clinical Practice, Human Retrovirus, Immunology +13

Biased TCR Repertoire in HIV-1-Infected Patients Due to Clonal Expansion of HIV-1-Reverse Transcriptase-Specific CTL Clones

Wasilis Kolowos, Matthias Schmitt, Marissa Herrman et al. · The Journal of Immunology · 1999 · 18 citations · Full text

No Evidence for Persistence of Multidrug-Resistant Viral Strains After a 7-Month Treatment Interruption in an HIV-1–Infected Individual

Hauke Walter, Peter Löw, Thomas Harrer et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2002 · 15 citations